Medpace Holdings - Stock

Medpace Holdings Liabilities 2024

Medpace Holdings Liabilities

1.1 B USD

Ticker

MEDP

ISIN

US58506Q1094

WKN

A2APTV

In 2024, Medpace Holdings's total liabilities amounted to 1.1 B USD, a 13.64% difference from the 966.1 M USD total liabilities in the previous year.

Medpace Holdings Aktienanalyse

What does Medpace Holdings do?

The company Medpace Holdings Inc is a global company specializing in conducting clinical trials and providing R&D services in the pharmaceutical and biotech industry. Medpace was founded in 1992 by Dr. August Troendle and is headquartered in Cincinnati, Ohio. Medpace's business model is based on offering a variety of services to pharmaceutical and biotech companies as a contract research organization (CRO), ranging from planning and conducting clinical trials to their evaluation. This includes regulatory consulting services, project management and data management, as well as monitoring and quality assurance. Medpace specializes in conducting complex studies for testing and approval of new drugs or medical technology products. However, the company also has experience in conducting post-marketing studies and supporting products that are already established in the global markets. Medpace's various divisions cover a wide range of therapy areas, from oncology and cardiovascular diseases to rare diseases and infectious diseases. The company has worked in over 60 countries and has 35 offices worldwide, including in Europe, Asia, and South America. Medpace has earned a reputation as a trusted partner in the planning, conducting, and evaluation of clinical trials and works closely with clients to understand their needs and requirements. The company has extensive experience working with regulatory authorities around the world and supports its clients in compliance with applicable regulations and requirements. Medpace's product portfolio includes a wide range of services tailored to the individual needs of its clients. These include: - Clinical trial management: Medpace supports clients in all aspects of planning, conducting, and monitoring clinical trials, including budget, personnel, and resource management. - Data management: Medpace offers comprehensive data management solutions, including data capture, validation, and storage, as well as a web-based platform for real-time data retrieval. - Regulatory consulting: Medpace provides support in all aspects of regulatory requirements, from preparation and submission of regulatory applications to monitoring and maintaining approvals. - Medical monitoring: Medpace provides experienced medical personnel to monitor the safety of study participants and assist in the monitoring of adverse events and interpretation of medical data. - Quality management: Medpace has a comprehensive quality management system that ensures all clinical trials are conducted according to the highest quality standards. Over the years, Medpace has received numerous awards and recognitions and is valued by its clients for its high quality, flexibility, and innovation. The company is constantly striving to improve its services and processes to meet the changing needs of the industry. Medpace Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Medpace Holdings's Liabilities

Medpace Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Medpace Holdings's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Medpace Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Medpace Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Medpace Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Medpace Holdings Stock

What is the level of liabilities of Medpace Holdings this year?

Medpace Holdings has a debt balance of 1.1 B USD this year.

What were the liabilities of Medpace Holdings compared to the previous year?

The liabilities of Medpace Holdings have increased by 13.64% increased compared to the previous year.

What are the consequences of high debt for investors of Medpace Holdings?

High liabilities can pose a risk for investors of Medpace Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Medpace Holdings?

Low liabilities mean that Medpace Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Medpace Holdings affect the company?

An increase in liabilities of Medpace Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Medpace Holdings affect the company?

A decrease in the liabilities of Medpace Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Medpace Holdings?

Some factors that can influence the liabilities of Medpace Holdings include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Medpace Holdings so important for investors?

The liabilities of Medpace Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Medpace Holdings take to modify the liabilities?

To change its liabilities, Medpace Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Medpace Holdings pay?

Over the past 12 months, Medpace Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medpace Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Medpace Holdings?

The current dividend yield of Medpace Holdings is .

When does Medpace Holdings pay dividends?

Medpace Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medpace Holdings?

Medpace Holdings paid dividends every year for the past 0 years.

What is the dividend of Medpace Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medpace Holdings located?

Medpace Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medpace Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medpace Holdings from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Medpace Holdings pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Medpace Holdings in the year 2023?

In the year 2023, Medpace Holdings distributed 0 USD as dividends.

In which currency does Medpace Holdings pay out the dividend?

The dividends of Medpace Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medpace Holdings

Our stock analysis for Medpace Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medpace Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.